REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/01/2026
Voltar para busca
Dado oficial do USPTO
KNOTBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
KNOTBODY
ST13
US500000088482082Classe
1, 5, 42, 44
Pedido
88482082
Registro
6248406
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
20/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
20/06/2019
Data de registro
19/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/01/2021
Última transação
20/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
REINO UNIOD, GB
Examinador
ERVIN, INGA
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MAXION THERAPEUTICS LIMITED
Iontas Ltd
Representantes
Ben Natter Haug Partners LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and scienceexcluding nanomaterial-based chemicals; biochemicalspolypeptides and antibodies for scientificlaboratory or research purposes; biochemicalspolypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicalsion channel blocking antibodies for scientificlaboratory or research purposes; biochemicalsion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicalsantibodies derived from mini-protein toxins for scientificlaboratory or research purposes; biochemicalsantibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
Classe 5
Pharmaceuticals and pharmaceutical preparations for the treatment of diseases and conditions associated with ion channel activity; drug delivery agents in the form of liquid preparations for infusion or injection that facilitate the delivery of pharmaceutical preparations; antibodies for medical useion channel blocking antibodies and antibodies derived from mini-protein toxins; pharmaceuticals and pharmaceutical preparations incorporating antibodiesion channel blocking antibodies or antibodies derived from mini-protein toxinsfor the treatment of diseases and conditions associated with ion channel activity
Classe 42
Scientific and technological servicesscientific researchanalysis and testing in the fields of pharmaceuticalsbiochemicalspolypeptidesantibodiesion channel blocking antibodies and antibodies derived from mini-protein toxins; drug discovery services and pharmaceutical drug development services; conducting or providing research and development services for others in the field of antibodies; scientific laboratory services relating to the production of antibodiesion channel blocking antibodies or antibodies derived from mini-protein toxins
Classe 44
Medical services; medical services connected with the treatment of diseases through the use of antibodiesion channel blocking antibodies or antibodies derived from mini-protein toxinspharmaceuticalsdrugs and pharmaceutical preparations derived from the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
19/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
19/01/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
17/12/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/12/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
28/10/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
26/10/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
26/10/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
26/10/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2020
PUBO
PUBLISHED FOR OPPOSITION
12/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/03/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
19/03/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/02/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/02/2020
CNSL
SUSPENSION LETTER WRITTEN
11/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/01/2020
ALIE
ASSIGNED TO LIE
13/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
11/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2019
NWAP
NEW APPLICATION ENTERED
24/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KNOTBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.